Osteoporosis Awareness

May is National Osteoporosis Awareness month. Osteoporosis is a disease that affects every human. It was identified by the WHO in the early 90s as a skeletal disease and we now know that it is associated with the aging process and affects more than just bone tissue.

The skeletal system is the foundation of the human body as it protects vital organs, and the muscles, ligaments and tendons ride on it and attach to it. It is vital for life and when it’s weakening, it can affect the immune system, account for slower reaction time, weaker functional strength, posture issues, organ and metabolic issues. Osteoporosis is called the silent killer because as we are aging, we lose on average 1 to 3 percent of skeletal mass every year until we die, and we never feel it changing.

There is a solution. Wolff’s law, discovered in 1892, established that if bones received efficient amounts of pressure, they would remain healthy and promote faster regrowth. This is why exercise is critical for bone development. In 2015, it was discovered that one needs impacts equal to 4.2 times the body weight to trigger osteogenesis, or new bone growth, in the hips. Unfortunately, most people can’t engage in heavy enough weight bearing exercise to keep the hips healthy with quality bone development. OsteoStrong helps people do this safely.

According to OsteoStrong owner, Josh Fandrich, “With proper nutrition, lifestyle changes and supplementation alongside strength training, you can develop a healthy bone matrix. So, love your bones and put them under performance just like you would your heart and muscles. It’s crucial for life.”

For more information, visit OsteoStrong.me or call for an appointment 251-586-8226 in Mobile or 251-210-6955 in Fairhope. See ad, page 17.

Reversing Type 2 Diabetes With Diet

A Type 2 diabetes (T2D) diagnosis is often regarded as a lifelong sentence and typically treated as such, requiring an increasing number of drugs. However, sustained remission of T2D is now well established.

In a recent primary care-based cohort study published in BMJ Nutrition, Prevention & Health, advice on a lowercarbohydrate diet and weight loss protocols was offered routinely to 9,800 patients with T2D between 2013 and 2021. Overall, remission was achieved in 51 percent of the patients that adopted a low-carb lifestyle, with individuals diagnosed with T2D within the previous year more likely to achieve remission (77 percent) than those that had been diagnosed for longer (20 percent for patients with a T2D duration greater than 15 years). Additionally, about 97 percent of the patients experienced improvements in blood glycemic control. Average low-density lipoprotein cholesterol and systolic blood pressure decreased, and there were also significant financial savings on drugs.